Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failurePaul G. Richardson, Robert J. Soiffer, Eneida R. Nemecek et al.|Blood|2016Cited by 333
Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)Naynesh Kamani, Shalini Shenoy, Mark C. Walters et al.|Transplantation and Cellular Therapy|2012Cited by 201
Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathiesAllison A. King, Shalini Shenoy, Naynesh Kamani et al.|American Journal of Hematology|2015Cited by 131
Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinopathies in ChildrenAllison A. King, Shalini Shenoy, Nancy Bunin et al.|Blood|2014Cited by 1
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 TrialPaul G. Richardson, Robert J. Soiffer, Nancy A. Kernan et al.|Transplantation and Cellular Therapy|2016Cited by 1